About
News
Calendar
Education & Training
Careers
How to Help
Contact Us
My Dana-Farber
Español
Find a Doctor
Get Directions
For Physicians
Make a Gift
Adult Care
Treatment and Care
Treatment Centers and Clinical Services
Care Team
Patient And Family Support
Care Quality and Patient Safety
Patient Stories
For Adult Cancer Survivors
Browse by Cancer Type
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
New Patient Guide
Planning a Visit
Driving Directions
Parking at Dana-Farber
Maps of Dana-Farber
Preparing for Your First Visit
How to Prepare
Talking to Your Doctor
Financial and Legal Matters
Insurance and Financial Assistance
Your Role as Patient
Ethics Consultation
Health Care Proxy
Special Assistance
Interpreters
Patient Navigators
Disability Services
Patient Safety and Advocacy
Safety Information
Patient Relations
Adult Patient and Family Advisory Council
Legislative Action Network
Amenities and Resources
Concierge Services
Appointments & Second Opinions
New Patient?
For appointments or second opinions:
Adults:
(877) 442-DFCI (442-3324)
Children:
(888) PEDI-ONC (733-4662)
or complete the
Appointment Request Form
Online Specialty Consultations
International Patients
Referring Physician?
To refer an adult patient:
(877) 441-DFCI (441-3324)
To refer a pediatric patient:
(888) PEDI-ONC (733-4662)
or complete the
Patient Referral Form
Pediatric Care
Treatment and Care
Pediatric Treatment Centers and Clinical Services
Care Team
Patient And Family Support
Care Quality and Patient Safety
Patient Stories
For Survivors of Childhood Cancer
Browse by Cancer Type
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
New Patient Guide
Planning a Visit
Driving Directions
Parking at Dana-Farber
Maps of Dana-Farber
Preparing for Your First Visit
How to Prepare
Talking to Your Child's Doctor
Financial and Legal Matters
Insurance and Financial Assistance
Your Role as Patient
Ethics Consultation
Health Care Proxy
Special Assistance
Interpreters
Disability Services
Patient Safety and Advocacy
Safety Information
Patient Relations
Legislative Action Network
Pediatric Patient and Family Advisory Council
Amenities and Resources
Concierge Services
Appointments & Second Opinions
New Patient?
For appointments or second opinions:
Adults:
(877) 442-DFCI (442-3324)
Children:
(888) PEDI-ONC (733-4662)
or complete the
Appointment Request Form
Your Child's Care Team
For International Patients
Referring Physician?
To refer an adult patient:
(877) 441-DFCI (441-3324)
To refer a pediatric patient:
(888) PEDI-ONC (733-4662)
or complete the
Patient Referral Form
Research
Clinical Trials
Research Advances
Featured Research
Departments and Centers
Integrative Research Centers
Core Facilities
Research Administration
Technology Transfer
Find a Researcher
Health Library
Blog
Home
Research
Clinical Trials
Clinical Trials by Diagnosis
Pediatric Hodgkin Lymphoma Clinical Trials
Showing 1-2 of 2 items
1.
Reduced Duration Stanford V Chemotherapy With or Without Low-Dose Tailored-Field Radiation Therapy For Favorable Risk Pediatric Hodgkin Lymphoma
This phase II trial is studying how well combination chemotherapy with or without radiation therapy works in treating young patients with favorable-risk Hodgkin lymphoma. Drugs used in chemotherapy, such as doxorubicin hydrochloride, vinblastine, mechlorethamine hydrochloride, cyclophosphamide, vincristine sulfate, bleomycin, etoposide, and prednisone, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more cancer cells. Radiation therapy uses high-energy x-rays to kill cancer cells for those patients that still had residual cancer at the end of chemotherapy. Giving combination chemotherapy with radiation therapy may kill more cancer cells and allow doctors to save the part of the body where the cancer started.
Diagnoses:
Pediatric Hodgkin Lymphoma
Status:
Recruiting
2.
Ipilimumab in Young Patients With Advanced or Refractory Solid Tumors
RATIONALE: Monoclonal antibodies, such as ipilimumab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find cancer cells and help kill them or carry cancer-killing substances to them. PURPOSE: This phase I trial is studying the side effects and best dose of ipilimumab in treating children, adolescents, and young adults with advanced or refractory solid tumors,
Diagnoses:
Pediatric Hodgkin Lymphoma
,
Pediatric Neuroblastoma
,
Pediatric Sarcoma
,
Pediatric Solid Tumors
,
Pediatric Lymphoma
,
Pediatric Wilms' Tumor
Status:
Recruiting
Showing 1-2 of 2 items
Email
Print
Share
Text
Highlight Glossary Terms